AArkstore enterprise 5th December 2014
Pompe Disease (GAA Deficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Browse Full Report @ http://www.aarkstore.com/pharmaceuticals-healthcare/60352/pompe-disease-gaadeficiency-therapeutics-pipeline-assessment-and-market-forecasts Published: Feb 2012 | No. Of Pages: 59 Pages PDF: $ 3995 | Site Licence : $ 7990 | Enterprise Wide Licence : $ 11985
Summary The industry analysis specialist, has released its new report, “Pompe Disease (GAA Deficiency) Therapeutics Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Pompe Disease (GAA Deficiency) Therapeutics market. The report identifies the key trends shaping and driving the global Pompe Disease (GAA Deficiency) Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Pompe Disease (GAA Deficiency) Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope The report provides information on the key drivers and challenges of the Pompe Disease (GAA Deficiency) Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Pompe Disease (GAA Deficiency) Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
Website : http://www.aarkstore.com/
AArkstore enterprise - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Pompe Disease (GAA Deficiency) Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Pompe Disease (GAA Deficiency) Therapeutics market. - Analysis of key recent licensing and partnership agreements in Pompe Disease (GAA Deficiency) Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Pompe Disease (GAA Deficiency) Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Pompe Disease (GAA Deficiency) Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Pompe Disease (GAA Deficiency) Therapeutics market landscape? – Identify, understand and capitalize.
Website : http://www.aarkstore.com/
AArkstore enterprise
Special Discount on Global Data Market Research Reports: Click here an avail Discount offer on Global Data market research reports: http://www.aarkstore.com/discount.php Discount Valid till 31st December 2014 For Research Reports Call us on: +91 9987295242 OR Mail us at contact@aarkstore.com
Tables Of Contents 2 Pompe Disease Therapeutics - Introduction 2.1 Overview 2.1.1 Classification 2.2 Epidemiology 2.2.1 Mortality/Morbidity
Website : http://www.aarkstore.com/
AArkstore enterprise 2.2.2 Race 2.2.3 Sex and Age 2.3 Etiology 2.4 Sign and Symptoms 2.4.1 Muscle & Movement Problems 2.4.2 Heart Problems 2.4.3 Breathing & Respiratory Problems 2.4.4 Feeding & Digestion Problems 2.5 Diagnosis 2.5.1 Diagnostic Delays in Patients 2.6 Pathophysiology 2.7 Treatment 2.7.1 Enzyme Replacement Therapy (ERT) 2.7.2 Gene Therapy 2.7.3 Enzyme Enhancement Therapy (EET) 2.7.4 Substrate Reduction Method 2.8 GlobalData Pipeline Report Guidance 3 Pompe Disease Therapeutics - Market Characterization 3.1 Pompe Disease Therapeutics Market Size (2006 - 2011) - Global 3.2 Pompe Disease Therapeutics Market Forecast (2011 - 2019) - Global 3.3 Pompe Disease Therapeutics Market Size (2006 - 2011) - The US 3.4 Pompe Disease Therapeutics Market Forecast (2011 - 2019) - The US 3.5 Pompe Disease Therapeutics Market Size (2006 - 2011) - France
Website : http://www.aarkstore.com/
AArkstore enterprise 3.6 Pompe Disease Therapeutics Market Forecast (2011 - 2019) - France 3.7 Pompe Disease Therapeutics Market Size (2006-2011) - Germany 3.8 Pompe Disease Therapeutics Market Forecast (2011 - 2019) - Germany 3.9 Pompe Disease Therapeutics Market Size (2006 - 2011) - Italy 3.10 Pompe Disease Therapeutics Market Forecast (2011 - 2019) - Italy 3.11 Pompe Disease Therapeutics Market Size (2006 - 2011) - Spain 3.12 Pompe Disease Therapeutics Market Forecast (2011 - 2019) - Spain 3.13 Pompe Disease Therapeutics Market Size (2006 - 2011) - The UK 3.14 Pompe Disease Therapeutics Market Forecast (2011 - 2019) - The UK 3.15 Pompe Disease Therapeutics Market Forecast (2006 - 2011) - Japan 3.16 Pompe Disease Therapeutics Market Forecast (2011 - 2019) - Japan 3.17 Drivers and Barriers for the Pompe Disease Therapeutics Market 3.17.1 Pompe Disease Therapeutics Market Drivers 3.17.2 Pompe Disease Therapeutics Market Barriers 3.18 Opportunity and Unmet Need 3.19 Key Takeaway 4 Pompe Disease Therapeutics - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profile for the Major Market Products in the Pompe Disease 4.3.1 Myozyme (Alglucosidase alfa) 4.4 Key Takeaway 5 Pompe Disease Therapeutics - Pipeline Assessment
Website : http://www.aarkstore.com/
AArkstore enterprise 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Pompe Disease Therapeutics Market - Pipeline Assessment by Phase of Development 5.3.1 Pompe Disease - Phase II Pipeline 5.3.2 Pompe Disease Therapeutics Market - Preclinical Pipeline 5.4 Pompe Disease Therapeutics - Pipeline by Mechanism of Action 5.5 Technology Trends Analytical Framework 5.6 Pompe Disease Therapeutics Market - Drugs Under Clinical Development 5.7 Pipeline Drug Profiles 5.7.1 Duvoglustat hydrochloride 5.7.2 rAAV1-CMV-GAA 5.8 Key Takeaway 6 Pompe Disease Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Region/Country (the US, EU5 and Japan) 6.2 Clinical Trials by Phase of Clinical Development 6.3 Clinical Trials by Trial Status 6.4 Prominent Sponsors 6.5 Brief Profiles of Top 10 Companies Participating in Therapeutics Clinical Trials 7 Pompe Disease Therapeutics - Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 Future Market Competition Scenario 8 Pompe Disease Therapeutics - Future Players 8.1 Introduction
Website : http://www.aarkstore.com/
AArkstore enterprise 8.2 Company Profiles 8.2.1 Amicus 8.2.2 Sanofi 8.2.3 Genzyme Corporation 8.2.4 BioMarin Pharmaceutical Inc. 8.3 Key Takeaway 9 Pompe Disease Therapeutics - Appendix 9.1 Market Definitions 9.2 Acronyms 9.3 Methodology 9.3.1 Coverage 9.3.2 Secondary Research 9.3.3 Forecasting 9.3.4 Primary Research 9.3.5 Expert Panel Validation 9.4 Contact Us 9.5 Disclaimer 9.6 Bibliography
List Of Tables Table 1: Pompe Disease Prevalence in Seven Major Markets Table 2: Pompe Disease Therapeutics Market, Global, Revenue ($m), 2006 - 2011 Table 3: Pompe Disease Therapeutics Market, Global, Forecast ($m), 2011 - 2019
Website : http://www.aarkstore.com/
AArkstore enterprise Table 4: Pompe Disease Therapeutics Market, The US, Revenue ($m), 2006 - 2011 Table 5: Pompe Disease Therapeutics Market, The US, Forecasts ($m), 2011 - 2019 Table 6: Pompe Disease Therapeutics Market, France, Revenue ($m), 2006 - 2011 Table 7: Pompe Disease Therapeutics Market, France, Forecasts ($m), 2011 - 2019 Table 8: Pompe Disease Therapeutics Market, Germany, Revenue ($m), 2006 - 2011 Table 9: Pompe Disease Therapeutics Market, Germany, Forecasts ($m), 2011 - 2019 Table 10: Pompe Disease Therapeutics Market, Italy, Revenue ($m), 2006 - 2011 Table 11: Pompe Disease Therapeutics Market, Italy, Forecasts ($m), 2011 - 2019 Table 12: Pompe Disease Therapeutics Market, Spain, Revenue ($m), 2006 - 2011 Table 13: Pompe Disease Therapeutics Market, Spain, Forecasts ($m), 2011 - 2019 Table 14: Pompe Disease Therapeutics Market, The UK, Revenue ($m), 2006 - 2011 Table 15: Pompe Disease Therapeutics Market, The UK, Forecasts ($m), 2011 - 2019 Table 16: Pompe Disease Therapeutics Market, Japan, Revenue ($m), 2006 - 2011 Table 17: Pompe Disease Therapeutics Market, Japan, Forecasts ($m), 2011 - 2019 Table 18: Pompe Disease Therapeutics - Phase II Pipeline, 2011 Table 19: Pompe Disease Therapeutics - Preclinical, 2011 Table 20: Pompe Disease Therapeutics - Drug in Clinical Development, 2011 Table 21: Pompe Disease Therapeutics - Clinical Trials by Country, 2011 Table 22: Pompe Disease Therapeutics, Major Markets - Clinical Trials by Phase, 2011 Table 23: Pompe Disease Therapeutics, Major Markets, Clinical Trials by Development Status, 2011 Table 24: Pompe Disease Therapeutics, Major Markets, Overall Sponsors, 2011 Table 25: Pompe Disease Therapeutics, Major Markets, Prominent Sponsors, 2011 Table 26: Pompe Disease Therapeutics Market - Companies Participating in Clinical Trials, 2011
Website : http://www.aarkstore.com/
AArkstore enterprise Table 27: Amicus Therapeutics Inc Pipeline Products, 2011
List Of Figures Figure 1: Diagnosis Algorithm for Older Patients Figure 2: Pompe Disease Therapeutics Market, Global, Revenue ($m), 2006 - 2011 Figure 3: Pompe Disease Therapeutics Market, Global, Forecast ($m), 2011 - 2019 Figure 4: Pompe Disease Therapeutics Market, The US, Forecast ($m), 2006 - 2011 Figure 5: Pompe Disease Therapeutics Market, The US, Forecasts ($m), 2011 - 2019 Figure 6: Pompe Disease Therapeutics Market, France, Revenue ($m), 2006 - 2011 Figure 7: Pompe Disease Therapeutics Market, France, Forecast ($m), 2011 - 2019 Figure 8: Pompe Disease Therapeutics Market, Germany, Revenue ($m), 2006 - 2011 Figure 9: Pompe Disease Therapeutics Market, Germany, Forecast ($m), 2011 - 2019 Figure 10: Pompe Disease Therapeutics Market, Italy, Revenue ($m), 2006 - 2011 Figure 11: Pompe Disease Therapeutics Market, Italy, Forecast ($m), 2011 - 2019 Figure 12: Pompe Disease Therapeutics Market, Spain, Revenue ($m), 2006 - 2011 Figure 13: Pompe Disease Therapeutics Market, Spain, Forecast ($m), 2011 - 2019 Figure 14: Pompe Disease Therapeutics Market, The UK, Revenue ($m), 2006 - 2011 Figure 15: Pompe Disease Therapeutics Market, The UK, Forecast ($m), 2011 - 2019 Figure 16: Pompe Disease Therapeutics Market, Japan, Revenue ($m), 2006 - 2011 Figure 17: Pompe Disease Therapeutics Market, Japan, Forecasts ($m), 2011 - 2019 Figure 18: Opportunity and Unmet Need in the Pompe Disease Therapeutics Market, 2011 Figure 19: Opportunity and Unmet Need in the Pompe Disease Therapeutics Market, 2011 Figure 20: Pompe Disease Therapeutics - Strategic Competitor Assessment, 2011
Website : http://www.aarkstore.com/
AArkstore enterprise Figure 21: Pompe Disease Therapeutics - Clinical Pipeline by Mechanism of Action, 2011 Figure 22: Pompe Disease Therapeutics Market - Pipeline by Phase of Development, 2011 Figure 23: Pompe Disease Therapeutics - Technology Trends Analytics Framework, 2011 Figure 24: Pompe Disease Therapeutics - Technology Trends Analytics Framework - Description, 2011 Figure 25: Pompe Disease Therapeutics - Clinical Trials by Country, 2011 Figure 26: Pompe Disease Therapeutics, Major Markets - Clinical Trials by Phase, 2011 Figure 27: Pompe Disease Therapeutics, Major Markets, Clinical Trials by Development Status, 2011 Figure 28: Pompe Disease Therapeutics, Overall Sponsors, 2011 Figure 29: Pompe Disease Therapeutics, Prominent Sponsors, 2011 Figure 30: Pompe Disease Therapeutics, Clinical Trials of Top 10 Companies by Phase, 2011 Figure 31: Pompe Disease Therapeutics Market, Drivers and Barriers 2011 Figure 32: Implications for Future Market Competition in the Pompe Disease Therapeutics Market, 2011 Figure 33: Pompe Disease Therapeutics Market - Clinical Pipeline by Company, 2011 Figure 34: GlobalData Market Forecasting Model
Discount Reports: Psychotic Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Amyloidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Cushing’s Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Sarcoidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Gaucher’s Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Toxoplasmosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Website : http://www.aarkstore.com/
AArkstore enterprise Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019 Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019 Gonorrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Addison’s Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
About Aarkstore Enterprise Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.
You can order full Report with TOC and Sample page visit: http://www.aarkstore.com/pharmaceuticals-healthcare/60352/pompe-disease-gaadeficiency-therapeutics-pipeline-assessment-and-market-forecasts
Contact Details: Aarkstore Enterprise Phone: +91 998 729 5242 Email: enquiry@aarkstore.com Our Website: http://www.aarkstore.com Facebook: https://www.facebook.com/aarkstoredotcom Linkedin: http://www.linkedin.com/company/aarkstore-enterprise
Website : http://www.aarkstore.com/
AArkstore enterprise
Website : http://www.aarkstore.com/